title: Development of delivery methods for carbohydrate-based drugs: controlled release of biologically-active short chain fatty acid-hexosamine analogs.
abstract: Carbohydrates are attractive candidates for drug development because sugars are involved in many, if not most, complex human diseases including cancer, immune dysfunction, congenital disorders, and infectious diseases. Unfortunately, potential therapeutic benefits of sugar-based drugs are offset by poor pharmacologic properties that include rapid serum clearance, poor cellular uptake, and relatively high concentrations required for efficacy. To address these issues, pilot studies are reported here where 'Bu(4)ManNAc', a short chain fatty acid-monosaccharide hybrid molecule with anti-cancer activities, was encapsulated in polyethylene glycol-sebacic acid (PEG-SA) polymers. Sustained release of biologically active compound was achieved for over a week from drug-laden polymer formulated into microparticles thus offering a dramatic improvement over the twice daily administration currently used for in vivo studies. In a second strategy, a tributanoylated ManNAc analog (3,4,6-O-Bu(3)ManNAc) with anti-cancer activities was covalently linked to PEG-SA and formulated into nanoparticles suitable for drug delivery; once again release of biologically active compound was demonstrated.
authors.affiliation: Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
authors.forename: Udayanath
authors.initials: U
authors.lastname: Aich
authors.forename: M Adam
authors.initials: MA
authors.lastname: Meledeo
authors.forename: Srinivasa-Gopalan
authors.initials: SG
authors.lastname: Sampathkumar
authors.forename: Jie
authors.initials: J
authors.lastname: Fu
authors.forename: Mark B
authors.initials: MB
authors.lastname: Jones
authors.forename: Christopher A
authors.initials: CA
authors.lastname: Weier
authors.forename: Sung Yun
authors.initials: SY
authors.lastname: Chung
authors.forename: Benjamin C
authors.initials: BC
authors.lastname: Tang
authors.forename: Ming
authors.initials: M
authors.lastname: Yang
authors.forename: Justin
authors.initials: J
authors.lastname: Hanes
authors.forename: Kevin J
authors.initials: KJ
authors.lastname: Yarema
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000138:chemical synthesis / Q000494:pharmacology; D002626:Chemistry, Pharmaceutical; D002851:Chromatography, High Pressure Liquid; D003652:Decanoic Acids / Q000737:chemistry; D003692:Delayed-Action Preparations; D003998:Dicarboxylic Acids / Q000737:chemistry; D016503:Drug Delivery Systems / Q000379:methods*; D005232:Fatty Acids, Volatile / Q000737:chemistry*; D006595:Hexosamines / Q000008:administration & dosage* / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D053758:Nanoparticles; D011092:Polyethylene Glycols / Q000737:chemistry; D011145:Polyvinyls / Q000737:chemistry
chemical_list: D000970:Antineoplastic Agents; D003652:Decanoic Acids; D003692:Delayed-Action Preparations; D003998:Dicarboxylic Acids; D005232:Fatty Acids, Volatile; D006595:Hexosamines; D011145:Polyvinyls; C013215:polyvinyl acetate; D011092:Polyethylene Glycols; C011107:sebacic acid; C002022:N-acetylmannosamine
references.citation: Glycobiology. 2009 Dec;19(12):1382-401
references.pmid: 19675091
references.citation: J Biol Chem. 1971 Jan 25;246(2):430-5
references.pmid: 5542012
references.citation: Nat Biotechnol. 2001 Jun;19(6):553-8
references.pmid: 11385460
references.citation: Lipids. 1986 Apr;21(4):267-70
references.pmid: 3713446
references.citation: J Biol Chem. 2004 Apr 30;279(18):18342-52
references.pmid: 14966124
references.citation: Clin Pharmacol Ther. 2008 May;83(5):761-9
references.pmid: 17957183
references.citation: J Biol Chem. 1992 Aug 25;267(24):16934-8
references.pmid: 1512235
references.citation: ChemMedChem. 2006 Nov;1(11):1164-94
references.pmid: 16983718
references.citation: Curr Opin Chem Biol. 2009 Dec;13(5-6):565-72
references.pmid: 19747874
references.citation: Chem Biol. 2006 Dec;13(12):1265-75
references.pmid: 17185222
references.citation: ACS Chem Biol. 2008 Apr 18;3(4):203-6
references.pmid: 18422301
references.citation: Biochemistry. 2003 Dec 30;42(51):15215-25
references.pmid: 14690432
references.citation: Bioorg Chem. 2005 Jun;33(3):216-28
references.pmid: 15888312
references.citation: Biochim Biophys Acta. 2007 Feb;1770(2):297-306
references.pmid: 17110045
references.citation: J Med Chem. 2009 Apr 23;52(8):2515-30
references.pmid: 19326913
references.citation: Biotechnol Bioeng. 2004 Feb 20;85(4):394-405
references.pmid: 14755557
references.citation: Biotechnol Prog. 2004 Nov-Dec;20(6):1674-82
references.pmid: 15575698
references.citation: Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3323-7
references.pmid: 7724561
references.citation: ACS Chem Biol. 2008 Apr 18;3(4):230-40
references.pmid: 18338853
references.citation: J Control Release. 2004 Jun 18;97(2):333-43
references.pmid: 15196760
references.citation: Nat Prod Rep. 2009 Mar;26(3):313-21
references.pmid: 19240943
references.citation: Biomaterials. 2002 Nov;23(22):4425-33
references.pmid: 12219833
references.citation: J Biol Chem. 2003 Mar 7;278(10):8035-42
references.pmid: 12499362
references.citation: Carbohydr Res. 2000 Nov 3;329(2):287-300
references.pmid: 11117312
references.citation: Mol Biosyst. 2007 Mar;3(3):187-94
references.pmid: 17308665
references.citation: J Med Chem. 2008 Dec 25;51(24):8135-47
references.pmid: 19053749
references.citation: Biochemistry. 2004 Sep 28;43(38):12358-66
references.pmid: 15379575